Princeton, NJ, United States of America

Yong Liu


Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yong Liu: Innovator in Pharmaceutical Research

Introduction

Yong Liu is a prominent inventor based in Princeton, NJ (US), known for his contributions to pharmaceutical research. He holds 2 patents that focus on innovative treatments for viral infections and neurodegenerative diseases. His work has significant implications for the development of new therapies.

Latest Patents

Yong Liu's latest patents include "Pseudopolymorphs of an HCV NS5A inhibitor and uses thereof." This invention relates to novel pseudopolymorphs of Compound A, which are useful for treating or preventing HCV infection in patients. Another notable patent is "Crystalline forms of a BACE inhibitor, compositions, and their use." This patent provides four crystalline forms of verubecestat, which may be beneficial in treating Alzheimer's disease and other Aβ pathologies.

Career Highlights

Yong Liu is currently employed at Merck Sharp & Dohme Corporation, where he continues to advance his research in the pharmaceutical field. His work is characterized by a commitment to developing effective treatments for complex diseases.

Collaborations

Yong Liu collaborates with talented colleagues, including Scott Trzaska and Zachary E Dance, to enhance the impact of his research and innovations.

Conclusion

Yong Liu's contributions to pharmaceutical research through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…